{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:14:42Z","timestamp":1791976482733,"version":"4.4.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1053\/j.gastro.2007.06.014","type":"journal-article","created":{"date-parts":[[2007,6,21]],"date-time":"2007-06-21T11:08:38Z","timestamp":1182424118000},"page":"755-760","source":"Crossref","is-referenced-by-count":106,"title":["Proton Pump Inhibitor Use and Risk of Colorectal Cancer: A Population-Based, Case\u2013Control Study"],"prefix":"10.1053","volume":"133","author":[{"given":"Douglas J.","family":"Robertson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Friis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik T.","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2007.06.014_bib1","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0016-5085(00)70004-7","article-title":"Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome","volume":"118","author":"Wolfe","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2007.06.014_bib2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0002-9343(01)00901-9","article-title":"Patterns of proton pump inhibitor use in clinical practice","volume":"111","author":"Barrison","year":"2001","journal-title":"Am J Med"},{"key":"10.1053\/j.gastro.2007.06.014_bib3","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJM199510263331703","article-title":"A comparison of five maintenance therapies for reflux esophagitis","volume":"333","author":"Vigneri","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2007.06.014_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-230X-2-17","article-title":"Are proton pump inhibitors the first choice for acute treatment of gastric ulcers?","volume":"2","author":"Salas","year":"2002","journal-title":"BMC Gastroenterol"},{"key":"10.1053\/j.gastro.2007.06.014_bib5","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/bmj.38356.641134.8F","article-title":"Systematic review and meta-analysis of proton pump inhibitor therapy in peptic ulcer bleeding","volume":"330","author":"Leontiadis","year":"2005","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2007.06.014_bib6","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1093\/ajhp\/55.21.2268","article-title":"Considerations for long-term use of proton-pump inhibitors","volume":"55","author":"Garnett","year":"1998","journal-title":"Am J Health Syst Pharm"},{"key":"10.1053\/j.gastro.2007.06.014_bib7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev.pa.35.040195.001425","article-title":"The pharmacology of the gastric acid pump: the H+,K+ ATPase","volume":"35","author":"Sachs","year":"1995","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1053\/j.gastro.2007.06.014_bib8","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/gut.25.9.957","article-title":"Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity","volume":"25","author":"Sharma","year":"1984","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2007.06.014_bib9","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0016-5085(90)90946-X","article-title":"Effect of long-term treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis","volume":"99","author":"Jansen","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2007.06.014_bib10","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1172\/JCI118993","article-title":"Processing and proliferative effects of human progastrin in transgenic mice","volume":"98","author":"Wang","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1053\/j.gastro.2007.06.014_bib11","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1172\/JCI4910","article-title":"Overexpression of glycine-extended gastrin in transgenic mice results in increased colonic proliferation","volume":"103","author":"Koh","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1053\/j.gastro.2007.06.014_bib12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3109\/00365529109093190","article-title":"Trophic effects of gastrin","volume":"180","author":"Hakanson","year":"1991","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1053\/j.gastro.2007.06.014_bib13","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/ijc.2910430425","article-title":"The in vitro growth response of primary human colorectal and gastric cancer cells to gastrin","volume":"43","author":"Watson","year":"1989","journal-title":"Int J Cancer"},{"key":"10.1053\/j.gastro.2007.06.014_bib14","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0016-5085(88)80075-1","article-title":"Effects of gastrin, proglumide, and somatostatin on growth of human colon cancer","volume":"95","author":"Smith","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2007.06.014_bib15","first-page":"7179","article-title":"Antiproliferative effects of gastrin receptor antagonists and antibodies to gastrin on human colon carcinoma cell lines","volume":"48","author":"Hoosein","year":"1988","journal-title":"Cancer Res"},{"key":"10.1053\/j.gastro.2007.06.014_bib16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ijc.2910610216","article-title":"Anti-gastrin antibodies raised by gastrimmune inhibit growth of the human colorectal tumour AP5","volume":"61","author":"Watson","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1053\/j.gastro.2007.06.014_bib17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00000658-198509000-00005","article-title":"Proglumide, a gastrin receptor antagonist, inhibits growth of colon cancer and enhances survival in mice","volume":"202","author":"Beauchamp","year":"1985","journal-title":"Ann Surg"},{"key":"10.1053\/j.gastro.2007.06.014_bib18","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/gut.41.3.330","article-title":"Rectal cell proliferation and colon cancer risk in patients with hypergastrinaemia","volume":"41","author":"Renga","year":"1997","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2007.06.014_bib19","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/BF02282349","article-title":"Prolonged hypergastrinemia does not increase the frequency of colonic neoplasia in patients with Zollinger-Ellison syndrome","volume":"41","author":"Orbuch","year":"1996","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2007.06.014_bib20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF01536047","article-title":"Elevated gastrin levels in patients with colon cancer or adenomatous polyps","volume":"34","author":"Smith","year":"1989","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2007.06.014_bib21","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1136\/gut.32.11.1352","article-title":"Postprandial hypergastrinaemia in patients with colorectal cancer","volume":"32","author":"Wong","year":"1991","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2007.06.014_bib22","first-page":"138","article-title":"Serum gastrin concentrations in colorectal cancer patients","volume":"74","author":"Charnley","year":"1992","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1053\/j.gastro.2007.06.014_bib23","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00004836-199110000-00013","article-title":"Elevated serum gastrin levels in patients with colorectal neoplasia","volume":"13","author":"Seitz","year":"1991","journal-title":"J Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2007.06.014_bib24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF01307566","article-title":"Gastrin and colorectal cancer","volume":"37","author":"Yapp","year":"1992","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2007.06.014_bib25","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/BF02552592","article-title":"Serum levels of gastrin in patients with colorectal neoplasia","volume":"31","author":"Suzuki","year":"1988","journal-title":"Dis Colon Rectum"},{"key":"10.1053\/j.gastro.2007.06.014_bib26","first-page":"1394","article-title":"Serum gastrin is not higher in subjects with colonic neoplasia","volume":"87","author":"Kikendall","year":"1992","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2007.06.014_bib27","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/0016-5085(94)90018-3","article-title":"Plasma gastrin concentrations are normal in patients with colorectal neoplasia and unaltered following tumor resection","volume":"106","author":"Penman","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2007.06.014_bib28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0016-5085(98)70193-3","article-title":"Gastrin and colorectal cancer: a prospective study","volume":"115","author":"Thorburn","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2007.06.014_bib29","first-page":"263","article-title":"The Danish National Hospital Register","volume":"46","author":"Andersen","year":"1999","journal-title":"Dan Med Bull"},{"key":"10.1053\/j.gastro.2007.06.014_bib30","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/oxfordjournals.aje.a116396","article-title":"Selection of controls in case-control studies","volume":"135","author":"Wacholder","year":"1992","journal-title":"Am J Epidemiol"},{"key":"10.1053\/j.gastro.2007.06.014_bib31","series-title":"Epidemiology: beyond the basics","author":"Szklo","year":"2000"},{"key":"10.1053\/j.gastro.2007.06.014_bib32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3233\/JRS-1997-10309","article-title":"The pharmacoepidemiologic prescription database of North Jutland-a valid tool in pharmacoepidemiological research","volume":"10","author":"Nielsen","year":"1997","journal-title":"Int J Risk Safety Med"},{"key":"10.1053\/j.gastro.2007.06.014_bib33","first-page":"445","article-title":"The Danish prescription registries","volume":"44","author":"Gaist","year":"1997","journal-title":"Dan Med Bull"},{"key":"10.1053\/j.gastro.2007.06.014_bib34","first-page":"55","article-title":"Descriptive tools and analysis","volume":"Volume European Series, No. 45","author":"Capella","year":"1993"},{"key":"10.1053\/j.gastro.2007.06.014_bib35","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/archinte.162.2.169","article-title":"Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole","volume":"162","author":"Graham","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.gastro.2007.06.014_bib36","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1053\/gast.2001.21907","article-title":"Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient","volume":"120","author":"Laine","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2007.06.014_bib37","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.294.8.914","article-title":"Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer","volume":"294","author":"Chan","year":"2005","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2007.06.014_bib38","series-title":"Danish classification of surgical procedures and therapies","year":"1973"},{"key":"10.1053\/j.gastro.2007.06.014_bib39","doi-asserted-by":"crossref","first-page":"232","DOI":"10.7326\/0003-4819-121-3-199408010-00012","article-title":"Omeprazole, hypergastrinemia, and gastric carcinoid tumors","volume":"121","author":"Freston","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2007.06.014_bib40","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1136\/gut.2005.090514","article-title":"Proton pump inhibitors and gastric neoplasia","volume":"55","author":"Kuipers","year":"2006","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2007.06.014_bib41","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1136\/gut.2005.086579","article-title":"Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK","volume":"55","author":"Garcia Rodriguez","year":"2006","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2007.06.014_bib42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00008469-200204000-00002","article-title":"A review of epidemiological studies on cancer in relation to the use of anti-ulcer drugs","volume":"11","author":"La Vecchia","year":"2002","journal-title":"Eur J Cancer Prev"},{"key":"10.1053\/j.gastro.2007.06.014_bib43","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.gie.2005.08.043","article-title":"Colorectal neoplasia in veterans is associated with Barrett\u2019s esophagus but not with proton-pump inhibitor or aspirin\/NSAID use","volume":"63","author":"Siersema","year":"2006","journal-title":"Gastrointest Endosc"},{"key":"10.1053\/j.gastro.2007.06.014_bib44","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/gut.52.7.942","article-title":"Mortality study of 18 000 patients treated with omeprazole","volume":"52","author":"Bateman","year":"2003","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2007.06.014_bib45","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/sj.bjc.6600945","article-title":"Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study","volume":"88","author":"Sorensen","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1053\/j.gastro.2007.06.014_bib46","series-title":"L\u00e6geforeningens Medicinfortegnelse 2005\/2006","author":"Hansen","year":"2005"},{"key":"10.1053\/j.gastro.2007.06.014_bib47","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.296.24.2947","article-title":"Long-term proton pump inhibitor therapy and risk of hip fracture","volume":"296","author":"Yang","year":"2006","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2007.06.014_bib48","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1463-1318.2006.01130.x","article-title":"Trends in colorectal cancer survival in northern Denmark: 1985\u20132004","volume":"9","author":"Iversen","year":"2007","journal-title":"Colorectal Dis"},{"key":"10.1053\/j.gastro.2007.06.014_bib49","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/01.STR.0000054057.11892.5B","article-title":"Nonaspirin nonsteroidal anti-inflammatory drugs and risk of hospitalization for intracerebral hemorrhage: a population-based case-control study","volume":"34","author":"Johnsen","year":"2003","journal-title":"Stroke"},{"key":"10.1053\/j.gastro.2007.06.014_bib50","first-page":"1","article-title":"Gastrins, cholecystokinins and gastrointestinal cancer","volume":"1704","author":"Aly","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1053\/j.gastro.2007.06.014_bib51","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1053\/gast.1997.v112.pm9041231","article-title":"Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia","volume":"112","author":"Eissele","year":"1997","journal-title":"Gastroenterology"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508507011559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508507011559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T06:19:40Z","timestamp":1587622780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508507011559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0016508507011559"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2007.06.014","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}